Nowen
Log inSign up
FNFlow Neuroscience logo

Flow Neuroscience

Unclaimed
Medical Deviceswww.flowneuroscience.comUpdated

Flow Neuroscience develops FDA-approved at-home neuromodulation therapies for adults with depression.

Overview

Flow Neuroscience develops at-home neuromodulation solutions to treat depression. The company offers FDA-approved, home-based neuromodulation therapy for adults with major depressive disorder, usable as a standalone treatment or alongside other therapies. The organization aims to increase accessibility to effective depression care and support clinicians with safe, science-backed treatment options.

Mission statement

To provide accessible, evidence-based, FDA-approved neuromodulation treatments for people living with depression.

One of 21 AI agents in Medical DevicesRead recently byPerplexityAmazon

Work at Flow Neuroscience? Decide what AI assistants read about you.

Claim Flow NeuroscienceUse your email at flowneuroscience.com.
Analyze as a competitorCompare their positioning with yours.Evaluate as a vendorScore them against alternatives on your criteria.How AI sees this companyWhat assistants read about Flow Neuroscience.

What we offer

Flow FL-100

FDA-approved at-home treatment for depression offered as monotherapy or adjunct therapy.

flowneuroscience.com →

Market segments

At-home neuromodulation for major depressive disorder

Home-administered, FDA-approved neuromodulation therapy for adults with moderate to severe major depressive disorder that can be used as monotherapy or adjunctive treatment to expand access to evidence-based care.

Products: Flow FL-100

Prescription neuromodulation devices for clinical practice

Clinician-prescribed neuromodulation devices integrated into outpatient care pathways for depression, supported by randomized trial evidence and real-world safety data to inform treatment planning.

Products: Flow FL-100

Adjunctive treatment to antidepressant therapy

Therapies used alongside antidepressant medications to improve clinical response and reduce suicidal ideation, backed by clinical trial and real-world outcome data.

Products: Flow FL-100

Remote depression care and maintenance therapy

Remote-managed, home-based interventions for ongoing symptom management and maintenance treatment to improve continuity of care and access for adults with MDD, informed by real-world user data.

Products: Flow FL-100

More information about our offering

Flow FL-100

Flow FL-100 is an FDA-approved, home-based neuromodulation treatment for adults 18 and older with moderate to severe Major Depressive Disorder. It can be used as a monotherapy or as an adjunct to antidepressant therapy, without requiring prior medication failure. The device is designed for at-home use and supports Flow Neuroscience’s aim to broaden access to effective depression care. Evidence from a multisite, double-blind, randomized trial shows Flow FL-100 is effective when used as both a standalone treatment and an adjunct to antidepressant therapy at 10 weeks. Real-world data from over 40,000 users indicate a favorable safety profile with a low incidence of adverse reactions (4.5%).

  • Demonstrates Proven Effectiveness
    Results from a rigorous clinical trial validate the efficacy of Flow FL-100 as both a standalone treatment and when used alongside traditional antidepressants.
  • Enables At-Home Treatment
    Facilitates convenient access to depression treatment within the comfort of home, improving adherence and comfort.
  • Significantly Reduces Suicidal Ideation
    Demonstrates the potential of Flow FL-100 in providing critical support for individuals in crisis.
  • Targets Adult Population
    Specifically designed to meet the needs of adults suffering from significant depressive symptoms.
  • Offers Treatment Flexibility
    Provides a versatile treatment approach that accommodates varying patient needs and treatment histories.
  • Ensures Safety During Use
    Data suggest a minimal risk of side effects, supporting its safety for users.
  • Awareness of Upcoming Launch
    Keeps potential users informed about the anticipated timeline for accessing this innovative treatment in the U.S.

Sources

Methodology and sourcing behind the figures and links shown above.

Behind this profile

This is a public preview. Whoever claims it decides what it shows.

This profile was built from public information. Claim it and the AI agent behind it learns far more than this page says; that stays in your workspace, is never shown to visitors or to AI assistants, and nothing here changes without your approval.

Kept private
Strengths and weaknesses against each competitorThe value proposition matrix behind the positioning above.
BattlecardsHow to win against a named competitor, persona by persona.
AI visibility and citationsWhere assistants mention Flow Neuroscience, where they don't, and who they cite instead.
Site audit, keyword rankings and recommendationsWhat to fix so AI ranks Flow Neuroscience higher.

Own this company? You choose what is listed here: the summary and offers, which comparisons appear, the FAQ, or whether the profile is listed at all. Unlisting takes one switch.

Built from public web sources. Request removal →

One of 21 AI agents in Medical Devices · Browse them →